Literature DB >> 16603919

18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.

Sandra Bense1, Christoph Best, Hans-Georg Buchholz, Valerie Wiener, Mathias Schreckenberger, Peter Bartenstein, Marianne Dieterich.   

Abstract

A patient with downbeat nystagmus was examined by F-fluorodeoxyglucose-positron emission tomography once while off and twice while on successful treatment with 4-aminopyridine. All positron emission tomography scans of the patient showed a reduced cerebral glucose metabolism bilaterally in the region of the cerebellar tonsil and flocculus/paraflocculus when compared with a normal database of the whole brain. An additional region-of-interest analysis revealed that 4-aminopyridine treatment lessened the hypometabolism. This finding supports the hypothesis that the cerebellar tonsil and (para-) flocculus play a crucial role in downbeat nystagmus. The hypometabolism might reflect reduced inhibition or even disinhibition of the circuits to the vestibular nuclei, thus causing downbeat nystagmus. The reduced hypometabolism during treatment probably indicates an improvement of the cerebellar inhibition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603919     DOI: 10.1097/00001756-200604240-00009

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  14 in total

Review 1.  What we know about the generation of nystagmus and other ocular oscillations: are we closer to identifying therapeutic targets?

Authors:  Rebecca Jane McLean; Irene Gottlob; Frank Antony Proudlock
Journal:  Curr Neurol Neurosci Rep       Date:  2012-06       Impact factor: 5.081

2.  Current treatment of vestibular, ocular motor disorders and nystagmus.

Authors:  Michael Strupp; Thomas Brandt
Journal:  Ther Adv Neurol Disord       Date:  2009-07       Impact factor: 6.570

Review 3.  Update on the Pharmacotherapy of Cerebellar Ataxia and Nystagmus.

Authors:  Katharina Feil; Tatiana Bremova; Carolin Muth; Roman Schniepp; Julian Teufel; Michael Strupp
Journal:  Cerebellum       Date:  2016-02       Impact factor: 3.847

Review 4.  The physiological basis of therapies for cerebellar ataxias.

Authors:  Hiroshi Mitoma; Mario Manto
Journal:  Ther Adv Neurol Disord       Date:  2016-05-20       Impact factor: 6.570

Review 5.  Telovelar surgical approach.

Authors:  Michael G Z Ghali
Journal:  Neurosurg Rev       Date:  2019-12-05       Impact factor: 3.042

Review 6.  Central oculomotor disturbances and nystagmus: a window into the brainstem and cerebellum.

Authors:  Michael Strupp; Katharina Hüfner; Ruth Sandmann; Andreas Zwergal; Marianne Dieterich; Klaus Jahn; Thomas Brandt
Journal:  Dtsch Arztebl Int       Date:  2011-03-25       Impact factor: 5.594

7.  Evidence for modulation of opioidergic activity in central vestibular processing: A [(18)F] diprenorphine PET study.

Authors:  Bernhard Baier; Sandra Bense; Frank Birklein; Hans-Georg Buchholz; Anja Mischke; Matthias Schreckenberger; Marianne Dieterich
Journal:  Hum Brain Mapp       Date:  2010-04       Impact factor: 5.038

Review 8.  [Pharmacotherapy of central oculomotor disorders].

Authors:  R Kalla; R Spiegel; J Wagner; N Rettinger; K Jahn; M Strupp
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

9.  Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q.

Authors:  Y H Cha; H Lee; J C Jen; J C Kattah; S F Nelson; R W Baloh
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05-23       Impact factor: 10.154

Review 10.  Central vestibular disorders.

Authors:  Marianne Dieterich
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.